<SEC-DOCUMENT>9999999995-24-001491.txt : 20240513
<SEC-HEADER>9999999995-24-001491.hdr.sgml : 20240513
<ACCEPTANCE-DATETIME>20240513001516
ACCESSION NUMBER:		9999999995-24-001491
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240510
DATE AS OF CHANGE:		20240513
EFFECTIVENESS DATE:		20240510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASI Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001962738
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-279096
		FILM NUMBER:		24936681

	BUSINESS ADDRESS:	
		STREET 1:		1701-1702, CHINA CENTRAL OFFICE TOWER 1
		STREET 2:		NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT
		CITY:			BEIJING
		STATE:			F4
		ZIP:			100025
		BUSINESS PHONE:		86 10 6561 8789

	MAIL ADDRESS:	
		STREET 1:		1701-1702, CHINA CENTRAL OFFICE TOWER 1
		STREET 2:		NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT
		CITY:			BEIJING
		STATE:			F4
		ZIP:			100025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CASI Pharmaceuticals Holdings, Inc.
		DATE OF NAME CHANGE:	20230118
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0101</schemaVersion>

    <submissionType>EFFECT</submissionType>

    <act>33</act>

    <testOrLive>LIVE</testOrLive>

    <effectiveData>
        <finalEffectivenessDispDate>2024-05-10</finalEffectivenessDispDate>
        <finalEffectivenessDispTime>16:00:00</finalEffectivenessDispTime>
        <form>F-3</form>
        <filer>
            <cik>0001962738</cik>
            <entityName>CASI Pharmaceuticals, Inc.</entityName>
            <fileNumber>333-279096</fileNumber>
        </filer>
    </effectiveData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
